Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GH Research

3 Biotech Stocks Wall Street Analysts Predict Will More Than Double

What makes analysts so bullish about these three names from the sector?

Depression-Focused GH Research Shares Could See Significant Upside: Analyst

Depression-Focused GH Research Shares Could See Significant Upside: Analyst

Needham initiated coverage on Monday for GH Research PLC (NASDAQ:GHRS), citing the company’s lead drug candidate, GH-001, which had demonstrated impressive efficacy in Phase 2 versus competition.

GH Research Shares Q2 2022 Financial Results & Business Updates

GH Research Shares Q2 2022 Financial Results & Business Updates

GH Research PLC (NASDAQ: GHRS), the clinical-stage biopharma company dedicated to transforming the treatment of psychiatric and neurological disorders through 5-MeO-DMT production, provided a financial and business update for the quarter ended June 30, 2022.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Psychedelic Stock Gainers And Losers From June 16, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.08% at $10.05 LOSERS:

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022

Cybin, GH Research Among Top Psychedelic Movers Of Today

GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75

GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today

GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS:

inkl

Read news from The Economist, FT, and more,
with one subscription

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS:

Psychedelic Stock Gainers And Losers From March 7, 2022

Psychedelic Stock Gainers And Losers From March 7, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 1.49% at $15.71 LOSERS:

Small Pharma, GH Research Among Top Psychedelic Movers Of Today

Small Pharma, GH Research Among Top Psychedelic Movers Of Today

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.99% at $0.24

Psychedelic Stock Gainers And Losers From January 21, 2022

Psychedelic Stock Gainers And Losers From January 21, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 1.18% at $17.19 LOSERS:

1

Organisations

Republic Services

Sanderson Farms

Eastman Chemical

Field Trip Health

Arthur J Gallagher

B.Riley Securities

DuPont de Nemours

Sally Beauty Holdings

Taylor Morrison Home

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

367,721 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play